Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Costs of dacomitinib versus placebo in pretreated...
Conference

Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26

Authors

Karim S; Ding K; Bradbury P; Ellis P; Mittman N; Sun XX; Millward M; Liu G; Sun S; Stockler MR

Volume

28

Publisher

OXFORD UNIV PRESS

Publication Date

September 1, 2017

Name of conference

42nd European-Society-for-Medical-Oncology Congress (ESMO)

Conference place

Madrid, SPAIN

Conference start date

September 8, 2017

Conference end date

September 12, 2017

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534